NCT00034684View on ClinicalTrials.gov

Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, ChronicBlast CrisisLeukemia, Lymphocytic
Interventions
DRUG

Farnesyl Protein Transferase Inhibitor

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00034684 - Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) | Biotech Hunter | Biotech Hunter